Top 10 U.S. healthcare companies by 2026 revenue | iPharmaCenter
Updated: Sep 1
Top 10 healthcare companies by revenues | 2026
Rank | Company | Q1 | H1 | 9M | 2026 revenues |
1 | United Health Group | $111.7 | $223.7 | ||
2 | CVS Health | $100.4 | $206.5 | ||
3 | Cigna Group | $68.5 | $140.0 | ||
4 | Centene | $49.9 | $103.5 | ||
5 | Elevance Health | $49.5 | $99.3 | ||
6 | Humana | $39.6 | $80.5 | ||
7 | Kaiser Permanente | $34.6 | |||
8 | HCA Healthcare | $19.1 | $39.3 | ||
9 | Molina Healthcare | $10.8 | $20.4 | ||
10 | Tenet Healthcare | $5.4 | $11.0 |
United Health Group
Q1 REVENUES:
UnitedHealth Group reported first-quarter 2026 revenues of $111.7 billion, representing a 2% increase from $109.6 billion in the prior-year period. Growth was supported by steady performance across its business segments, with
UnitedHealthcare generating $86.3 billion in revenue, including $20.1 billion from Employer & Individual plans, $42.1 billion from Medicare & Retirement, and $24.1 billion from Community & State, the latter rising 4% year-over-year driven by Medicaid rate updates.
Optum contributed $63.7 billion in total revenues, led by Optum Rx at $35.7 billion, up 2% on specialty pharmacy growth despite some membership attrition, while Optum Health reported $24.1 billion, down 3% due to fewer value-based care members, and Optum Insight posted $5.1 billion, slightly higher than the previous year.
UnitedHealth Group recorded corporate eliminations of $38.3 billion in the first quarter of 2026.
Also read: FDA Approval of Sarclisa Escena Marks Shift Toward Subcutaneous Oncology Delivery
Q2 REVENUES:
UnitedHealth Group announced its financial performance for the second quarter of 2026, reporting total revenues of $112.0 billion during the period.
Within its insurance division, UnitedHealthcare generated $86.0 billion in revenue, slightly below the $86.1 billion recorded in the same quarter of 2025. The segment covered approximately 48.5 million individuals in Q2 2026, reflecting a sequential decline of about 525,000 members.
The Employer & Individual business segment posted revenues of $20.0 billion, up from $19.8 billion a year earlier. However, total enrollment in this segment fell by roughly 145,000 members during the quarter, primarily due to reductions in both self-funded employer plans and fully insured offerings.
Optum Health reported revenues of $23.5 billion in the second quarter, representing a 5% year-over-year decrease. This decline was largely driven by a reduction of approximately 700,000 patients participating in value-based care programs.
Optum Insight continued to expand its technology-driven healthcare solutions portfolio, introducing AI-powered tools such as automated medical coding and digital prior authorization systems. The division also finalized the acquisition of Alegeus on July 2, 2026, strengthening its position in consumer-directed healthcare financial services. Optum Insight recorded revenues of $5.4 billion for the quarter.
Optum Rx, the pharmacy benefit management arm, generated $38.3 billion in revenue in Q2 2026, compared with $38.5 billion in the corresponding quarter of the previous year.
Also read: Germany Enacts 2026 Healthcare Reform to Curb Statutory Insurance Spending
CVS Health
Q1 REVENUES:
CVS Health reported total revenues of $100.4 billion in the first quarter of 2026, driven by contributions from its three operating segments.
The Health Care Benefits segment, which offers a full range of insured and self-insured (“ASC”) medical, pharmacy, dental and behavioral health products and services, generated $36.0 billion in revenue.
Also read: Germany Enacts 2026 Healthcare Reform to Curb Statutory Insurance Spending
The Health Services segment, which provides a full range of pharmacy benefit management solutions, delivers health care services in its medical clinics, virtually, and in the home, and offers provider enablement solutions, reported $48.2 billion in revenue.
The Pharmacy and Consumer Wellness segment, which dispenses prescriptions in its retail pharmacies and through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs and vaccination administration, and sells a wide assortment of health and wellness products and general merchandise, delivered $32.0 billion in revenue in the quarter.
Also read: Aetna Survey Highlights Evolving Payer-Provider Confidence Landscape
Q2 REVENUES/H1 REVENUES
CVS Health reported second-quarter 2026 total revenue of $106.1 billion, a 7.3 percent increase compared to the same period last year.
For the first six months of 2026, the company’s combined revenue reached $206.5 billion, reflecting growth across all major business lines.
Health Care Benefits Segment Generates $73.5 Billion
The Health Care Benefits division, which delivers insured and self-insured medical, pharmacy, dental, and behavioral health solutions, contributed $73.5 billion in revenue during the first half of 2026. This segment continues to serve millions of members through employer plans, government programs, and individual policies.
Health Services Division Reaches $100.0 Billion in H1
CVS Health’s Health Services segment, offering pharmacy benefit management, clinic-based and virtual care, home health services, and provider enablement tools, recorded $100.0 billion in revenue for the first half of the year. The unit has been a key growth driver as integrated care models expand.
Pharmacy & Consumer Wellness Adds $65.8 Billion
The Pharmacy & Consumer Wellness segment, which includes retail prescription dispensing, infusion services, vaccination programs, and sales of health and general merchandise, posted $65.8 billion in revenue over the first six months of 2026. This business remains a core part of CVS’s community health footprint.
Cigna Group
Q1 REVENUES:
The Cigna Group reported total revenues of $68.5 billion in the first quarter of 2026, with the business largely driven by Evernorth Health Services and supported by Cigna Healthcare.
The Evernorth Health Services segment, which includes the Pharmacy Benefit Services and Specialty and Care Services operating segments, generated $58.4 billion in revenue, reflecting strong growth in pharmacy and specialty services. The Cigna Healthcare segment, which comprises the U.S. Healthcare and International Health operating segments and provides comprehensive medical and coordinated solutions to clients and customers, reported $11.5 billion in revenue in the quarter, a decline versus the prior year mainly due to the HCSC transaction.
Q2 REVENUES/H1 REVENUES
Cigna Group reported stronger second-quarter results for 2026, with total revenue climbing 7 percent to $71.7 billion. For the first half of the year, the company’s combined revenue reached $140.2 billion, reflecting steady expansion across its core businesses.
Evernorth Health Services Leads Top-Line Performance
The Evernorth Health Services unit, which brings together pharmacy benefit management along with specialty and care services, was a major driver of growth. Pharmacy Benefit Services generated $67.5 billion in revenue, while Specialty and Care Services contributed $52.4 billion during the period.
Cigna Healthcare Segment Adds $23.2 Billion in Revenue
Cigna Healthcare, covering both U.S. healthcare and international health operations, posted revenue of $23.2 billion. This segment continues to deliver coordinated medical solutions and integrated care options to clients and members across multiple markets.
Centene Health
Q1 REVENUES:
Centene reported total revenues of $49.9 billion in the first quarter.
Premium and service revenues came in at $44.6 billion. Medicaid contributed $23.6 billion to premium and service revenues. Commercial business generated $9.6 billion in premium and service revenues. Medicare added $10.3 billion to premium and service revenues.
Q2 REVENUES/H1 REVENUES
Centene posted second-quarter 2026 revenue of $53.5 billion, with premium and service revenues accounting for $44.4 billion of the total.
The company’s membership base stood at 12.1 million in Medicaid plans and 4.0 million in commercial coverage during the quarter.
First-Half 2026 Revenue Reaches $103.5 Billion
For the first six months of 2026, Centene’s total revenue came to $103.5 billion. Medicaid operations contributed $60.9 billion, while Medicare-related business added $21.4 billion. Commercial lines generated $18.9 billion over the same period.
Elevance Health
Q2 REVENUES:
Elevance Health reported operating revenue of $49.8 billion in the second quarter of 2026, up $0.4 billion from the prior-year period. The increase was supported by stronger premium yields in Health Benefits and higher product revenue in CarelonRx. This was partly offset by expected membership declines in Medicare Advantage, Medicaid, and Employer Group risk-based businesses.
Health Benefits generated operating revenue of $42.7 billion, rising $1.1 billion, or 3 percent, from the prior-year quarter. Carelon posted operating revenue of $19.2 billion, up $1.1 billion, or 6 percent, while operating gain reached $0.9 billion, supported by stronger specialty pharmacy profitability.
The revenues from the first half of 2026 were $99.3 billion. The revenues from health revenues were $85.2 billion, CarelonRx were $21.9 billion, and Carelon Services were $15.3 billion.
Humana
Kaiser Permanente
HCA Healthcare
Q2 REVENUES/H1 REVENUES
HCA Healthcare reported strong revenue growth for the second quarter of 2026, with revenues increasing 8.7 percent to $20.230 billion compared with the prior-year period.
For the first six months ended June 30, 2026, revenues totaled $39.339 billion, up from $36.926 billion a year earlier, reflecting continued demand across the company’s hospital and healthcare services network.
HCSC
Molina Healthcare
Q2 REVENUES/H1 REVENUES:
HCA Healthcare generated revenues of $21.6 billion in the first half of 2026, reflecting a solid performance across its payer portfolio. Medicaid accounted for $16.0 billion of revenues, while Medicare contributed $3.0 billion and marketplace plans added $1.4 billion over the period.
As of June 30, 2026, the company served approximately 4.9 million members, underscoring its scale as one of the largest healthcare providers in the United States.
Comments